Literature DB >> 18436145

Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations.

Carol Ann Remme1, Arthur A M Wilde, Connie R Bezzina.   

Abstract

Cardiac sodium channel dysfunction caused by mutations in the SCN5A gene is associated with a number of relatively uncommon arrhythmia syndromes, including long-QT syndrome type 3 (LQT3), Brugada syndrome, conduction disease, sinus node dysfunction, and atrial standstill, which potentially lead to fatal arrhythmias in relatively young individuals. Although these various arrhythmia syndromes were originally considered separate entities, recent evidence indicates more overlap in clinical presentation and biophysical defects of associated mutant channels than previously appreciated. Various SCN5A mutations are now known to present with mixed phenotypes, a presentation that has become known as "overlap syndrome of cardiac sodium channelopathy." In many cases, multiple biophysical defects of single SCN5A mutations are suspected to underlie the overlapping clinical manifestations. Here, we provide an overview of current knowledge on SCN5A mutations associated with sodium channel overlap syndromes and discuss a possible role for modifiers in determining disease expressivity in the individual patient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18436145     DOI: 10.1016/j.tcm.2008.01.002

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  77 in total

Review 1.  Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins.

Authors:  Michael J Ackerman; Peter J Mohler
Journal:  Circ Res       Date:  2010-08-20       Impact factor: 17.367

Review 2.  The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.

Authors:  Johannes Steinfurt; Jürgen Biermann; Christoph Bode; Katja E Odening
Journal:  Dtsch Arztebl Int       Date:  2015-06-05       Impact factor: 5.594

Review 3.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 4.  Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death.

Authors:  Hugues Abriel; Jean-Sébastien Rougier; José Jalife
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

5.  Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome.

Authors:  Dan Hu; Hector Barajas-Martinez; Vladislav V Nesterenko; Ryan Pfeiffer; Alejandra Guerchicoff; Jonathan M Cordeiro; Anne B Curtis; Guido D Pollevick; Yuesheng Wu; Elena Burashnikov; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2009-12-16       Impact factor: 1.976

6.  Atrial Fibrillation and SCN5A Variants.

Authors:  Eleonora Savio-Galimberti; Dawood Darbar
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

7.  FGF12 is a candidate Brugada syndrome locus.

Authors:  Jessica A Hennessey; Cherisse A Marcou; Chuan Wang; Eric Q Wei; Chaojian Wang; David J Tester; Margherita Torchio; Federica Dagradi; Lia Crotti; Peter J Schwartz; Michael J Ackerman; Geoffrey S Pitt
Journal:  Heart Rhythm       Date:  2013-10-04       Impact factor: 6.343

Review 8.  Regulation of intracellular and mitochondrial sodium in health and disease.

Authors:  Elizabeth Murphy; David A Eisner
Journal:  Circ Res       Date:  2009-02-13       Impact factor: 17.367

9.  The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium.

Authors:  C A Remme; A O Verkerk; W M H Hoogaars; W T J Aanhaanen; B P Scicluna; C Annink; M J B van den Hoff; A A M Wilde; T A B van Veen; M W Veldkamp; J M T de Bakker; V M Christoffels; C R Bezzina
Journal:  Basic Res Cardiol       Date:  2009-03-03       Impact factor: 17.165

10.  Genome-wide association study of PR interval.

Authors:  Arne Pfeufer; Charlotte van Noord; Kristin D Marciante; Dan E Arking; Martin G Larson; Albert Vernon Smith; Kirill V Tarasov; Martina Müller; Nona Sotoodehnia; Moritz F Sinner; Germaine C Verwoert; Man Li; W H Linda Kao; Anna Köttgen; Josef Coresh; Joshua C Bis; Bruce M Psaty; Kenneth Rice; Jerome I Rotter; Fernando Rivadeneira; Albert Hofman; Jan A Kors; Bruno H C Stricker; André G Uitterlinden; Cornelia M van Duijn; Britt M Beckmann; Wiebke Sauter; Christian Gieger; Steven A Lubitz; Christopher Newton-Cheh; Thomas J Wang; Jared W Magnani; Renate B Schnabel; Mina K Chung; John Barnard; Jonathan D Smith; David R Van Wagoner; Ramachandran S Vasan; Thor Aspelund; Gudny Eiriksdottir; Tamara B Harris; Lenore J Launer; Samer S Najjar; Edward Lakatta; David Schlessinger; Manuela Uda; Gonçalo R Abecasis; Bertram Müller-Myhsok; Georg B Ehret; Eric Boerwinkle; Aravinda Chakravarti; Elsayed Z Soliman; Kathryn L Lunetta; Siegfried Perz; H-Erich Wichmann; Thomas Meitinger; Daniel Levy; Vilmundur Gudnason; Patrick T Ellinor; Serena Sanna; Stefan Kääb; Jacqueline C M Witteman; Alvaro Alonso; Emelia J Benjamin; Susan R Heckbert
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.